Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability
Open Access
- 7 August 2011
- journal article
- gastrointestinal
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 21 (12), 2567-2574
- https://doi.org/10.1007/s00330-011-2220-5
Abstract
To assess the influence of region of interest (ROI) size and positioning on tumour ADC measurements and interobserver variability in patients with locally advanced rectal cancer (LARC). Forty-six LARC patients were retrospectively included. Patients underwent MRI including DWI (b0,500,1000) before and 6–8 weeks after chemoradiation (CRT). Two readers measured mean tumour ADCs (pre- and post-CRT) according to three ROI protocols: whole-volume, single-slice or small solid samples. The three protocols were compared for differences in ADC, SD and interobserver variability (measured as the intraclass correlation coefficient; ICC). ICC for the whole-volume ROIs was excellent (0.91) pre-CRT versus good (0.66) post-CRT. ICCs were 0.53 and 0.42 for the single-slice ROIs versus 0.60 and 0.65 for the sample ROIs. Pre-CRT ADCs for the sample ROIs were significantly lower than for the whole-volume or single-slice ROIs. Post-CRT there were no significant differences between the whole-volume ROIs and the single-slice or sample ROIs, respectively. The SDs for the whole-volume and single-slice ROIs were significantly larger than for the sample ROIs. ROI size and positioning have a considerable influence on tumour ADC values and interobserver variability. Interobserver variability is worse after CRT. ADCs obtained from the whole tumour volume provide the most reproducible results. Key Points • ROI size and positioning influence tumour ADC measurements in rectal cancer • ROI size and positioning influence interobserver variability of tumour ADC measurements • ADC measurements of the whole tumour volume provide the most reproducible results • Tumour ADC measurements are more reproducible before, rather than after, chemoradiation treatment • Variations caused by ROI size and positioning should be taken into account when using ADC as a biomarker for tumour responseKeywords
This publication has 28 references indexed in Scilit:
- The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancerActa Oncologica, 2010
- Diffusion-Weighted Imaging of Mucinous Carcinoma of the Breast: Evaluation of Apparent Diffusion Coefficient and Signal Intensity in Correlation With Histologic FindingsAmerican Journal of Roentgenology, 2009
- Prostate Cancer: Apparent Diffusion Coefficient Map with T2-weighted Images for Detection—A Multireader StudyRadiology, 2009
- Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapyNature Clinical Practice Oncology, 2008
- Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor modelRadiotherapy and Oncology, 2007
- A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapySurgical Endoscopy, 2007
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion CoefficientsAmerican Journal of Roentgenology, 2007
- Patterns of Failure and Survival for Nonoperative Treatment of Stage c0 Distal Rectal Cancer Following Neoadjuvant Chemoradiation TherapyJournal of Gastrointestinal Surgery, 2006
- Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PETBiomedicine & Pharmacotherapy, 2004